Literature DB >> 17093385

Outbreak of polio in adults--Namibia, 2006.

.   

Abstract

After 10 years with no detected wild poliovirus (WPV) transmission in Namibia, an outbreak of poliomyelitis cases occurred in 2006. The outbreak was traced to importation from neighboring Angola of WPV type 1 (WPV1) that originated in India. As of October 2, 2006, a total of 19 cases of polio, with paralysis onset between early May and June 26, had been confirmed by isolation of WPV1 from stool specimens, primarily from young adult males; six of the patients died. This report describes outbreak investigation and response activities and provides an update on routine and supplemental immunization activities (SIAs) and acute flaccid paralysis (AFP) surveillance in Namibia.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17093385

Source DB:  PubMed          Journal:  MMWR Morb Mortal Wkly Rep        ISSN: 0149-2195            Impact factor:   17.586


  9 in total

1.  Seroprevalence of antipolio antibodies among children <15 years of age in border provinces in China.

Authors:  HaiBo Wang; Hui Cui; ZhenGrong Ding; Pian Ba; ShuangLi Zhu; Ning Wen; LiXin Hao; Jing Ning; Jie Zhang; De Yang; WenBo Xu; Yong Zhang; ChunXiang Fan; WenZhou Yu; XiaoFeng Liang; HuiMing Luo
Journal:  Clin Vaccine Immunol       Date:  2013-05-15

2.  Global polio perspective.

Authors:  M Steven Oberste; Howard L Lipton
Journal:  Neurology       Date:  2014-05-20       Impact factor: 9.910

3.  Immunity to polio, measles and rubella in women of child-bearing age and estimated congenital rubella syndrome incidence, Cambodia, 2012.

Authors:  B Mao; K Chheng; K Wannemuehler; E Vynnycky; S Buth; S C Soeung; S Reef; W Weldon; L Quick; C J Gregory
Journal:  Epidemiol Infect       Date:  2014-11-06       Impact factor: 4.434

4.  Physiotherapy for poliomyelitis: a descriptive study in the Republic of Congo.

Authors:  Silvia Mancini; Matthew E Coldiron; Sarala Nicholas; Augusto E Llosa; Isabelle Mouniaman-Nara; Joseph Ngala; Rebecca F Grais; Klaudia Porten
Journal:  BMC Res Notes       Date:  2014-10-23

5.  Overview of Polio Outbreak Response in Kenya, 2013 to 2015.

Authors:  Chidiadi Nwogu; Johnny Musyoka; Carolyne Gathenji; Rosemary Nzunza; Iheoma Onuekwusi; Joseph Okeibunor; Pascal Mkanda; Hemant Shukla; Shaikh Humayun Kabir; Sam O Okiror
Journal:  J Immunol Sci       Date:  2021-04-02

6.  An evaluation of the sensitivity of acute flaccid paralysis surveillance for poliovirus infection in Australia.

Authors:  Rochelle E Watkins; P Anthony J Martin; Heath Kelly; Ben Madin; Charles Watson
Journal:  BMC Infect Dis       Date:  2009-09-30       Impact factor: 3.090

7.  [Investigation and response to an outbreak of wild poliovirus in Kinshasa].

Authors:  Muriel Nzazi Nsambu; Léodegal Bazira; Tiekoura Coulibaly; Albert Mbule; Michèle Dramaix Wilmet; Joris Losimba Likwela
Journal:  Pan Afr Med J       Date:  2013-05-31

8.  Enhanced surveillance of acute flaccid paralysis following importation of wild poliovirus in Xinjiang Uygur Autonomous Region, China.

Authors:  Ning Wen; Chun-Xiang Fan; Jian-Ping Fu; Jing Ning; Yi-Xin Ji; Hui-Ming Luo; Hua-Qing Wang; Shuang-Li Zhu; Wen-Zhou Yu; Hai-Bo Wang; Hui Zhu; Fu-Qiang Cui; De-Xin Li; Shi-Wen Wang; Wen-Bo Xu; Li-Xin Hao; Ling-Sheng Cao; Li Luo; Lu Han; Lei Cao; Wei Xia; Xin-Qi Wang; Kathleen H Reilly; Fuerhati Wushouer; Sha-Sha Mi; Wei-Zhong Yang; Li Li
Journal:  BMC Infect Dis       Date:  2014-02-27       Impact factor: 3.090

9.  Sero-survey of polio antibodies during wild poliovirus outbreak in southern Xinjiang Uygur Autonomous Region, China.

Authors:  Hai-Bo Wang; Shuang-Li Zhu; Jing-Shan Zheng; Ai-Li Gou; Hui Cui; Yong Zhang; Gui-Jun Ning; Chun-Xiang Fan; Yuan-Sheng Chen; Ke-Li Li; Ping Yuan; Chao Ma; Jing Ma; Hui Zheng; Xin-Chun Fan; Xin-Lan Li; Hai-Shu Tang; Xiao-Lei Li; Fan Zhang; Dong-Mei Yan; Dong-Yan Wang; Zhi-Qiang Cui; Li-Ping Ren; Hui Zhu; Hui-Ling Wang; Xiao-Hong Jiang; Hong-Qiu An; Yang Liu; Jing Li; Wen-Bo Xu; Ning Wen; Ai-Qiang Xu; Hui-Ming Luo
Journal:  PLoS One       Date:  2014-07-03       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.